Literature DB >> 24093856

A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification.

Faisal M Merchant1, Hui Zheng, Thomas Bigger, Richard Steinman, Takanori Ikeda, Roberto F E Pedretti, Jorge A Salerno-Uriarte, Catherine Klersy, Paul S Chan, Cheryl Bartone, Stefan H Hohnloser, Jeremy N Ruskin, Antonis A Armoundas.   

Abstract

BACKGROUND: Although left ventricular ejection fraction (LVEF) is the primary determinant for sudden cardiac death (SCD) risk stratification, in isolation, LVEF is a sub-optimal risk stratifier. We assessed whether a multi-marker strategy would provide more robust SCD risk stratification than LVEF alone.
METHODS: We collected patient-level data (n = 3355) from 6 studies assessing the prognostic utility of microvolt T-wave alternans (MTWA) testing. Two thirds of the group was used for derivation (n = 2242) and one-third for validation (n = 1113). The discriminative capacity of the multivariable model was assessed using the area under the receiver-operating characteristic curve (c-index). The primary endpoint was SCD at 24 months.
RESULTS: In the derivation cohort, 59 patients experienced SCD by 24 months. Stepwise selection suggested that a model based on 3 parameters (LVEF, coronary artery disease and MTWA status) provided optimal SCD risk prediction. In the derivation cohort, the c-index of the model was 0.817, which was significantly better than LVEF used as a single variable (0.637, P < .001). In the validation cohort, 36 patients experienced SCD by 24 months. The c-index of the model for predicting the primary endpoint was again significantly better than LVEF alone (0.774 vs 0.671, P = .020).
CONCLUSIONS: A multivariable model based on presence of coronary artery disease, LVEF and MTWA status provides significantly more robust SCD risk prediction than LVEF as a single risk marker. These findings suggest that multi-marker strategies based on different aspects of the electro-anatomic substrate may be capable of improving primary prevention implantable cardioverter-defibrillator treatment algorithms.
© 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24093856      PMCID: PMC4188429          DOI: 10.1016/j.ahj.2013.06.023

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  44 in total

1.  T-wave alternans as a predictor for sudden cardiac death after myocardial infarction.

Authors:  Takanori Ikeda; Hirokazu Saito; Kaoru Tanno; Hiroki Shimizu; Jun Watanabe; Yoshio Ohnishi; Yuji Kasamaki; Yukio Ozawa
Journal:  Am J Cardiol       Date:  2002-01-01       Impact factor: 2.778

2.  Prognostic significance of risk stratifiers of mortality, including T wave alternans, after acute myocardial infarction: results of a prospective follow-up study.

Authors:  J M Tapanainen; A M Still; K E Airaksinen; H V Huikuri
Journal:  J Cardiovasc Electrophysiol       Date:  2001-06

Review 3.  Interpretation and classification of microvolt T wave alternans tests.

Authors:  Daniel M Bloomfield; Stefan H Hohnloser; Richard J Cohen
Journal:  J Cardiovasc Electrophysiol       Date:  2002-05

4.  Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.

Authors:  Mark J Boogers; C Jan Willem Borleffs; Maureen M Henneman; Rutger J van Bommel; Jan van Ramshorst; Eric Boersma; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2010-06-15       Impact factor: 24.094

Review 5.  Left ventricular ejection fraction for sudden death risk stratification and guiding implantable cardioverter-defibrillators implantation.

Authors:  Alfred E Buxton; Kristin E Ellison; Peem Lorvidhaya; Ohad Ziv
Journal:  J Cardiovasc Pharmacol       Date:  2010-05       Impact factor: 3.105

6.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

7.  Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy.

Authors:  Hidetsuna Kitamura; Yoshio Ohnishi; Katsunori Okajima; Akihiko Ishida; ErdulfoJavier Galeano; Kazumasa Adachi; Mitsuhiro Yokoyama
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

8.  Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure.

Authors:  T Klingenheben; M Zabel; R B D'Agostino; R J Cohen; S H Hohnloser
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

9.  Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study.

Authors:  Stefan H Hohnloser; Thomas Klingenheben; Daniel Bloomfield; Omar Dabbous; Richard J Cohen
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

10.  Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.

Authors:  Paul S Chan; Brahmajee K Nallamothu; John A Spertus; Frederick A Masoudi; Cheryl Bartone; Dean J Kereiakes; Theodore Chow
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-01-06
View more
  4 in total

Review 1.  Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.

Authors:  Massimo Iacoviello; Francesco Monitillo
Journal:  World J Cardiol       Date:  2014-07-26

2.  Predicting the outcomes for out-of-hospital cardiac arrest patients using multiple biomarkers and suspension microarray assays.

Authors:  Chien-Hua Huang; Min-Shan Tsai; Kuo-Liong Chien; Wei-Tien Chang; Tzung-Dau Wang; Shyr-Chyr Chen; Matthew Huei-Ming Ma; Hsin-Yun Hsu; Wen-Jone Chen
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

Review 3.  Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view.

Authors:  Marcello Disertori; Michele M Gulizia; Giancarlo Casolo; Pietro Delise; Andrea Di Lenarda; Giuseppe Di Tano; Maurizio Lunati; Luisa Mestroni; Jorge Salerno-Uriarte; Luigi Tavazzi
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2016-04       Impact factor: 2.160

Review 4.  Cardiac magnetic resonance imaging: Which information is useful for the arrhythmologist?

Authors:  Elia De Maria; Annachiara Aldrovandi; Ambra Borghi; Letizia Modonesi; Stefano Cappelli
Journal:  World J Cardiol       Date:  2017-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.